ColoAlert test identifies novel mRNA biomarkers in colorectal cancer, study shows

Mainz Biomed and Thermo Fisher collaborate to develop next-gen global CRC screening product

Mainz Biomed, a molecular genetics diagnostic company specializing in the early detection of cancer, announced a collaborative agreement with Thermo Fisher Scientific Inc. through its subsidiary Life Technologies Corporation.

November 15, 2024

Vol.50 No.43

In Brief

Cathy Eng named associate director of strategic relations and research partnerships at Vanderbilt-Ingram

Cathy Eng, David H. Johnson Professor of Surgical and Medical Oncology, was named associate director of strategic relations and research partnerships for Vanderbilt-Ingram Cancer Center.

October 18, 2024

Vol.50 No.39

In Brief

UCLA researchers receive $3M NIH grant for CRC screening follow-up in underserved communities

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center were awarded a $3 million grant from NIH to improve follow-up care for colorectal cancer screening in underserved populations.

October 04, 2024

Vol.50 No.37

In Brief

Vanderbilt receives $1M grant to fund immunotherapy research in CRC

The Robert J. Kleberg Jr. and Helen C. Kleberg Foundation awarded a $1 million grant to support research at Vanderbilt aimed at dramatically expanding the efficacy of immunotherapy for colorectal cancer.

October 04, 2024

Vol.50 No.37

Clinical Roundup

Circadian disruption, gut microbiome changes linked to CRC progression in mice

Research from the University of California, Irvine revealed how disruption of the circadian clock may accelerate the progression of colorectal cancer by affecting the gut microbiome and intestinal barrier function.

October 04, 2024

Vol.50 No.37

Drugs & Targets

FDA approves Cologuard Plus Test for non-invasive CRC screening

FDA approved the Cologuard Plus test, a multitarget stool DNA test. The Cologuard Plus test is now approved for adults ages 45 and older who are at average risk for colorectal cancer.

October 04, 2024

Vol.50 No.37

ColoAlert test identifies novel mRNA biomarkers in colorectal cancer, study shows

YOU MAY BE INTERESTED IN

Mainz Biomed and Thermo Fisher collaborate to develop next-gen global CRC screening product

Cathy Eng named associate director of strategic relations and research partnerships at Vanderbilt-Ingram

UCLA researchers receive $3M NIH grant for CRC screening follow-up in underserved communities

Vanderbilt receives $1M grant to fund immunotherapy research in CRC

Circadian disruption, gut microbiome changes linked to CRC progression in mice

FDA approves Cologuard Plus Test for non-invasive CRC screening

Renew today!

Subscriber content

Never miss an issue!

Login